Spotlight on Testing: The Promise and Limitations of COVID-19 Antibody Testing — What We Know So Far

Originally published on May 20, 2020


Lecture Presenters

Julio C. Delgado, MD, MS

Julio C. Delgado, MD, MS

Chief Medical Officer/Director of Laboratories
ARUP Laboratories
Professor of Pathology
University of Utah School of Medicine

Dr. Julio C. Delgado is the chief medical officer and director of laboratories at ARUP Laboratories and the chief of the division of clinical pathology at the University of Utah. Dr. Delgado graduated with a medical degree from the Universidad Industrial de Santander. He received a master’s degree in epidemiology from the Harvard School of Public Health, where he also completed his residency in pathology. Dr. Delgado served as the chief resident at Brigham and Women’s Hospital and later completed a postdoctoral fellowship in immunogenetics at Dana-Farber Cancer Institute. He also completed postdoctoral training in immunology at the CBR Institute for Biomedical Research. Dr. Delgado is certified by the American Board of Pathology and the American Board of Histocompatibility. His research areas of focus include immunogenecity to monoclonal antibody therapeutics and transplantation immunology.


Brian R. Jackson, MD, MS

Brian R. Jackson, MD, MS

Medical Director, Business Development, IT and Support Services
ARUP Laboratories
Associate Professor of Clinical Pathology; Adjunct Associate Professor of Biomedical Informatics
University of Utah School of Medicine

Dr. Jackson is the medical director for Business Development, Support Services and IT at ARUP and an associate professor of pathology (clinical) at the University of Utah School of Medicine. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah, and completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Prior to his employment at ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the University of Utah. Dr. Jackson’s research interests include economic analysis of diagnostic testing, physician utilization of laboratory tests, and corporate social responsibility in healthcare. He is certified in clinical pathology by the American Board of Pathology.


Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories